DK235687A - Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf - Google Patents

Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf

Info

Publication number
DK235687A
DK235687A DK235687A DK235687A DK235687A DK 235687 A DK235687 A DK 235687A DK 235687 A DK235687 A DK 235687A DK 235687 A DK235687 A DK 235687A DK 235687 A DK235687 A DK 235687A
Authority
DK
Denmark
Prior art keywords
preparations
hydroxyphetic
prostaglandines
synthesis
acids
Prior art date
Application number
DK235687A
Other languages
English (en)
Other versions
DK235687D0 (da
DK167518B1 (da
Inventor
Klaus Ulrich Weithmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of DK235687D0 publication Critical patent/DK235687D0/da
Publication of DK235687A publication Critical patent/DK235687A/da
Application granted granted Critical
Publication of DK167518B1 publication Critical patent/DK167518B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK235687A 1986-05-09 1987-05-08 Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse af disse til fremstilling af laegemidler DK167518B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863615710 DE3615710A1 (de) 1986-05-09 1986-05-09 Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
DE3615710 1986-05-09

Publications (3)

Publication Number Publication Date
DK235687D0 DK235687D0 (da) 1987-05-08
DK235687A true DK235687A (da) 1987-11-10
DK167518B1 DK167518B1 (da) 1993-11-15

Family

ID=6300504

Family Applications (1)

Application Number Title Priority Date Filing Date
DK235687A DK167518B1 (da) 1986-05-09 1987-05-08 Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse af disse til fremstilling af laegemidler

Country Status (16)

Country Link
US (1) US5043328A (da)
EP (1) EP0244832B1 (da)
JP (1) JPS62267222A (da)
KR (1) KR950008306B1 (da)
AT (1) ATE77549T1 (da)
AU (1) AU603574B2 (da)
CA (1) CA1302266C (da)
DE (2) DE3615710A1 (da)
DK (1) DK167518B1 (da)
ES (1) ES2051705T3 (da)
GR (1) GR3005768T3 (da)
HU (1) HU201671B (da)
IE (1) IE60273B1 (da)
IL (1) IL82459A (da)
PT (1) PT84841B (da)
ZA (1) ZA873299B (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2639828B1 (fr) * 1988-12-01 1993-11-05 Lvmh Recherche Utilisation du kaempferol et de certains de ses derives pour la preparation d'une composition cosmetique ou pharmaceutique
DK173585B1 (da) * 1989-11-09 2001-04-02 Asta Medica Ag Anvendelse af alfa-liponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus
ES2033193B1 (es) * 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
US5399584A (en) * 1992-05-05 1995-03-21 The Procter & Gamble Company Use of flavone derivatives for gastroprotection
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
WO1994015464A1 (en) * 1993-01-15 1994-07-21 Abbott Laboratories Structured lipids
GB9715444D0 (en) * 1997-07-22 1997-09-24 Scotia Holdings Plc Therapeutic and dietary compositions
AU784123B2 (en) * 1999-10-13 2006-02-09 Marco A. Chacon Therapeutic intervention to mimic the effect of caloric restriction
MXPA02004413A (es) * 1999-11-02 2002-09-02 Depomed Inc Induccion farmacologica del modo de alimentacion, para la administracion aumentada de drogas al estomago.
US6228367B1 (en) * 1999-12-22 2001-05-08 Renew Life, Inc. Food supplement formulation
CA2304906A1 (en) * 2000-04-07 2001-10-07 1411198 Ontario Limited 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
WO2005108535A2 (en) * 2004-04-30 2005-11-17 Nutriscience Technology, Inc. Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
EP1517667A2 (en) * 2002-07-02 2005-03-30 Galileo Pharmaceuticals, Inc. Compositions and methods for reduction of inflammatory symptoms and/or biomarkers in female subjects
US20050164908A1 (en) * 2004-01-23 2005-07-28 Ginsberg Myron D. Neuroprotective complex for treatment of cerebral ischemia and injury
GB0403247D0 (en) 2004-02-13 2004-03-17 Tillotts Pharma Ag A pharmaceutical composition
WO2006054316A1 (en) * 2004-11-16 2006-05-26 Magene Life Sciences Private Limited Method(s) of preparation, stabilization, composition, and administration of gamma-linolenic acid for brain tumors
US20070082063A1 (en) * 2005-10-11 2007-04-12 Douglas Bibus Risk assessment and correction of membrane damage of the upper GI tract
US8372425B2 (en) * 2008-10-31 2013-02-12 Lipid Pharmaceuticals Ehf. Fatty acids for use as a medicament
EP2595625B1 (en) * 2010-07-22 2016-04-20 Ramot at Tel-Aviv University Ltd. Pharmaceutical composition containing a tryptophan derivative
WO2013087808A1 (en) 2011-12-15 2013-06-20 Merz Pharma Gmbh & Co. Kgaa Pharmaceutical composition comprising a pyrazolopyrimidme and cyclodextrin
US9518155B2 (en) 2012-04-16 2016-12-13 Rhodia Operations Fluoropolymer compositions
GB201216385D0 (en) 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
US10143219B2 (en) * 2013-03-06 2018-12-04 Rutgers, The State University Of New Jersey Nutritional supplement/feed formula and methods of use thereof to reduce development of Osteochondrosis Dissecans (OCD) lesions

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE237029C (da) *
FR2197605A1 (en) * 1972-09-06 1974-03-29 Williams John Foodstuff or skin nutrient to combat cholesterolaemia - contains arachidonic acid or gamma linolenic acid or esters and salts thereof
JPS537492B2 (da) * 1973-02-12 1978-03-18
GB1476624A (en) * 1973-05-30 1977-06-16 Cepbepe Tranquiliser medicaments
DE2813814A1 (de) * 1978-03-31 1979-10-18 Boehringer Mannheim Gmbh Hochwirksame, enteral resorbierbare pharmazeutische praeparate
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS5735512A (en) * 1980-06-27 1982-02-26 Nippon Oil & Fats Co Ltd Preventive and remedy for thrombosis
JPS5813541A (ja) * 1981-07-16 1983-01-26 Kureha Chem Ind Co Ltd エイコサペンタエン酸又はドコサヘキサエン酸のシクロデキストリン包接化合物
DE3366506D1 (en) * 1982-03-01 1986-11-06 Efamol Ltd Pharmaceutical composition
FR2522935A1 (fr) * 1982-03-10 1983-09-16 Chevalier Jacques Nouveaux produits a base de lait et de ses derives riches en acides gras polyinsatures et leur procede de preparation
JPS58164508A (ja) * 1982-03-26 1983-09-29 Eisai Co Ltd イソプレニルカルボン酸含有外用組成物
EP0093516B1 (en) * 1982-04-29 1986-10-01 Efamol Limited Pharmaceutical composition
US4668704A (en) * 1982-08-09 1987-05-26 Regents Of The University Of California Method for protecting and healing gastro-duodenal mucosa and the liver of mammals
ATE55056T1 (de) * 1982-12-09 1990-08-15 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
CA1218376A (en) * 1983-05-28 1987-02-24 Sekimoto, Hiroshi Compositions containing unsaturated fatty acid compounds and method of stabilizing unsaturated fatty acid compounds
CA1239587A (en) * 1983-10-24 1988-07-26 David Rubin Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
DE3470277D1 (en) * 1984-01-11 1988-05-11 Von Mletzko Armin Dietetic composition
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
DE3719097C1 (de) * 1987-06-06 1988-06-09 Fratzer Uwe Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E

Also Published As

Publication number Publication date
HU201671B (en) 1990-12-28
EP0244832B1 (de) 1992-06-24
PT84841B (pt) 1990-02-08
KR870010867A (ko) 1987-12-18
AU603574B2 (en) 1990-11-22
PT84841A (de) 1987-06-01
EP0244832A2 (de) 1987-11-11
DE3779958D1 (de) 1992-07-30
ES2051705T3 (es) 1994-07-01
KR950008306B1 (ko) 1995-07-27
ZA873299B (en) 1987-11-02
DE3615710A1 (de) 1987-11-26
AU7264187A (en) 1987-11-12
US5043328A (en) 1991-08-27
ATE77549T1 (de) 1992-07-15
IE60273B1 (en) 1994-06-29
EP0244832A3 (en) 1989-11-29
DK235687D0 (da) 1987-05-08
JPS62267222A (ja) 1987-11-19
CA1302266C (en) 1992-06-02
HUT44433A (en) 1988-03-28
IE871203L (en) 1987-11-09
GR3005768T3 (da) 1993-06-07
IL82459A (en) 1994-07-31
IL82459A0 (en) 1987-11-30
DK167518B1 (da) 1993-11-15

Similar Documents

Publication Publication Date Title
DK235687A (da) Tilberedninger til syntese af prostaglandiner og hydroxyfedtsyrer i biologiske systemer og anvendelse deraf
NO873753D0 (no) Periodisk biologisk luftbehandlingsprosess og system for denne.
DK93388A (da) Lav-virusvarianter, dna- og proteinbestanddele deraf og anvendelse deraf, saerlig til diagnostiske formaal og til fremstilling af immunogene praeparater
ES2063515T3 (es) Ifn-alfa o-glucosilados.
ES2021868B3 (es) Procedimiento para la determinacion de la natremia de un paciente y riñon artificial para su aplicacion.
DK614987A (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
NO873699D0 (no) Polypeptid som er egnet til dempning, behandling og diagnosering av autoimmune lidelser saasom leddbetennelser.
ES2022454B3 (es) Sistema terapeutico para la liberacion controlada de drogas.
NO853466L (no) Stabilisert, smussfrigjoeringsbefordrende polymer av polyethylenterefthalat og polyoxethylenterefthalat og fremgangsmaate for fremstilling av denne.
NO872712D0 (no) Fremgangsmaate for fremstilling av kalsiumholdige preparater.
NO905605D0 (no) Medisinsk middel for aa behandle mastitt hos dyr og mennesker.
NO881510D0 (no) Sterilt formeringssystem.
NO880197D0 (no) Pelsdyrfor og fremgangsmaate til fremstilling derav.
FI844645L (fi) 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar.
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
NO883987D0 (no) Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter.
IT1172306B (it) Procedimento per la produzione e la immobilizzazione di proteine modificate
NO912230D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive anellerte dihydropyridinyleddiksyrer.
NO885058L (no) 6-oxoprostaglandin-e-derivater, fremgangsmaater for fremstilling av disse og deres farmasoeytiske anvendelse.
IT1215534B (it) Procedimento per la realizzazione di giunti impermeabili in diaframmi e diaframma relativo.
NO875144L (no) Plant, terapeutisk system, fremgangsmÿte for fremstilling og anvendelse derav.
IT8720186A0 (it) Procedimento per la preparazione di biopolimeri.
NO884921D0 (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.
ATE18132T1 (de) Pharmazeutische praeparate zur behandlung von nagelentzuendungen.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK